Drug interactions in the pharmacotherapy of patients included in primary care comprehensive medication management services

Objective: A drug interaction (DI) is the clinical event in which the effect or action of one drug is modified by the presence of another. Because of potential harms and low consistency of available information, it is critical to assess the clinical relevance of DI. This study aimed to identify and...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hágabo M. SILVA, Djenane RAMALHO-DE-OLIVEIRA, Ursula M. MARTINS, Yone A. NASCIMENTO, Adriano M. REIS, Aline A. SANTOS, Mariana G. NASCIMENTO
Formato:	article
Lenguaje:	EN PT
Publicado:	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2021
Materias:	conduta do tratamento medicamentoso interações medicamentosas atenção primária à saúde Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/fee886b8fe6a4cf392b072fde42721cb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fee886b8fe6a4cf392b072fde42721cb
record_format	dspace
spelling	oai:doaj.org-article:fee886b8fe6a4cf392b072fde42721cb2021-11-28T02:43:11ZDrug interactions in the pharmacotherapy of patients included in primary care comprehensive medication management services10.30968/rbfhss.2021.122.05452179-59242316-7750https://doaj.org/article/fee886b8fe6a4cf392b072fde42721cb2021-06-01T00:00:00Zhttps://www.rbfhss.org.br/sbrafh/article/view/545https://doaj.org/toc/2179-5924https://doaj.org/toc/2316-7750 Objective: A drug interaction (DI) is the clinical event in which the effect or action of one drug is modified by the presence of another. Because of potential harms and low consistency of available information, it is critical to assess the clinical relevance of DI. This study aimed to identify and evaluate the clinical consequences of DI in the pharmacotherapy of patients followed in a primary care Comprehensive Medication Management (CMM) services. Methods: This observational cross-sectional study was based on the analysis of the CMM records all the patients that used at least two medications and attended to at least three CMM consultations from August 2015 to March 2016 (n=88). Potential DI were identified among the medications used in the initial consultation of CMM using Micromedex® Drug-Reax® software. The DI were classified as “monitorable” (when its clinical consequences could be monitored by effectiveness or safety paremeters) or non-monitorable, and their clinical consequences were evaluated by analysis of CMM records. Results: Among the studied population 95.5% of the patients had at least one potential DI in their pharmacotherapy, totaling 493 potential DI. Of all the potential DIs identified, 90.9% were monitorable, and the majority of these monitorable DI presented no clinical consequences (62.7%). For 63.9% of the DI with clinical impact, the pharmacist adopted direct or indirect measures that would favor the resolution or reduction of the clinical impact of DIs. Conclusion: The CMM service facilitates the management of DIs since its decision-making method calls for monitoring of the effectiveness and safety parameters, individualizing the management of DIs according to the patient’s needs and their clinical consequences. Hágabo M. SILVADjenane RAMALHO-DE-OLIVEIRAUrsula M. MARTINSYone A. NASCIMENTOAdriano M. REISAline A. SANTOSMariana G. NASCIMENTOSociedade Brasileira de Farmácia Hospitalar e Serviços de Saúdearticleconduta do tratamento medicamentosointerações medicamentosasatenção primária à saúdePublic aspects of medicineRA1-1270Pharmacy and materia medicaRS1-441Therapeutics. PharmacologyRM1-950ENPTRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 12, Iss 2 (2021)
institution	DOAJ
collection	DOAJ
language	EN PT
topic	conduta do tratamento medicamentoso interações medicamentosas atenção primária à saúde Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
spellingShingle	conduta do tratamento medicamentoso interações medicamentosas atenção primária à saúde Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950 Hágabo M. SILVA Djenane RAMALHO-DE-OLIVEIRA Ursula M. MARTINS Yone A. NASCIMENTO Adriano M. REIS Aline A. SANTOS Mariana G. NASCIMENTO Drug interactions in the pharmacotherapy of patients included in primary care comprehensive medication management services
description	Objective: A drug interaction (DI) is the clinical event in which the effect or action of one drug is modified by the presence of another. Because of potential harms and low consistency of available information, it is critical to assess the clinical relevance of DI. This study aimed to identify and evaluate the clinical consequences of DI in the pharmacotherapy of patients followed in a primary care Comprehensive Medication Management (CMM) services. Methods: This observational cross-sectional study was based on the analysis of the CMM records all the patients that used at least two medications and attended to at least three CMM consultations from August 2015 to March 2016 (n=88). Potential DI were identified among the medications used in the initial consultation of CMM using Micromedex® Drug-Reax® software. The DI were classified as “monitorable” (when its clinical consequences could be monitored by effectiveness or safety paremeters) or non-monitorable, and their clinical consequences were evaluated by analysis of CMM records. Results: Among the studied population 95.5% of the patients had at least one potential DI in their pharmacotherapy, totaling 493 potential DI. Of all the potential DIs identified, 90.9% were monitorable, and the majority of these monitorable DI presented no clinical consequences (62.7%). For 63.9% of the DI with clinical impact, the pharmacist adopted direct or indirect measures that would favor the resolution or reduction of the clinical impact of DIs. Conclusion: The CMM service facilitates the management of DIs since its decision-making method calls for monitoring of the effectiveness and safety parameters, individualizing the management of DIs according to the patient’s needs and their clinical consequences.
format	article
author	Hágabo M. SILVA Djenane RAMALHO-DE-OLIVEIRA Ursula M. MARTINS Yone A. NASCIMENTO Adriano M. REIS Aline A. SANTOS Mariana G. NASCIMENTO
author_facet	Hágabo M. SILVA Djenane RAMALHO-DE-OLIVEIRA Ursula M. MARTINS Yone A. NASCIMENTO Adriano M. REIS Aline A. SANTOS Mariana G. NASCIMENTO
author_sort	Hágabo M. SILVA
title	Drug interactions in the pharmacotherapy of patients included in primary care comprehensive medication management services
title_short	Drug interactions in the pharmacotherapy of patients included in primary care comprehensive medication management services
title_full	Drug interactions in the pharmacotherapy of patients included in primary care comprehensive medication management services
title_fullStr	Drug interactions in the pharmacotherapy of patients included in primary care comprehensive medication management services
title_full_unstemmed	Drug interactions in the pharmacotherapy of patients included in primary care comprehensive medication management services
title_sort	drug interactions in the pharmacotherapy of patients included in primary care comprehensive medication management services
publisher	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
publishDate	2021
url	https://doaj.org/article/fee886b8fe6a4cf392b072fde42721cb
work_keys_str_mv	AT hagabomsilva druginteractionsinthepharmacotherapyofpatientsincludedinprimarycarecomprehensivemedicationmanagementservices AT djenaneramalhodeoliveira druginteractionsinthepharmacotherapyofpatientsincludedinprimarycarecomprehensivemedicationmanagementservices AT ursulammartins druginteractionsinthepharmacotherapyofpatientsincludedinprimarycarecomprehensivemedicationmanagementservices AT yoneanascimento druginteractionsinthepharmacotherapyofpatientsincludedinprimarycarecomprehensivemedicationmanagementservices AT adrianomreis druginteractionsinthepharmacotherapyofpatientsincludedinprimarycarecomprehensivemedicationmanagementservices AT alineasantos druginteractionsinthepharmacotherapyofpatientsincludedinprimarycarecomprehensivemedicationmanagementservices AT marianagnascimento druginteractionsinthepharmacotherapyofpatientsincludedinprimarycarecomprehensivemedicationmanagementservices
_version_	1718408478918180864

Drug interactions in the pharmacotherapy of patients included in primary care comprehensive medication management services

Ejemplares similares